Samjin Pharmaceutical Co Ltd
KRX:005500
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Samjin Pharmaceutical Co Ltd
Other Receivables
Samjin Pharmaceutical Co Ltd
Other Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Samjin Pharmaceutical Co Ltd
KRX:005500
|
Other Receivables
₩6.1B
|
CAGR 3-Years
411%
|
CAGR 5-Years
232%
|
CAGR 10-Years
44%
|
|
|
Yuhan Corp
KRX:000100
|
Other Receivables
₩19.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-1%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Other Receivables
₩13.3B
|
CAGR 3-Years
167%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Other Receivables
₩1.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-13%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Other Receivables
₩9.9B
|
CAGR 3-Years
41%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Other Receivables
₩261m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
Samjin Pharmaceutical Co Ltd
Glance View
Samjin Pharmaceutical Co., Ltd. engages in the manufacture, distribution, and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 755 full-time employees. The Company’s products include antipyretics, analgesics, antiphlogistic agents, osteoarthritis agents, osteopathic agents, antihistaminic agents, circulatory system drugs, gastrointestinal agents, osteoporosis treatments, hepatic disease agents, respiratory agents, antibiotics agents, detoxifying agents, antifungal agents, antineoplastic agents and others. Its products are provided in the forms of tablets, injections, capsules and others. The company distributes its products to the hospitals and drugstores. The firm supplies its products within domestic market and to overseas markets.
See Also
What is Samjin Pharmaceutical Co Ltd's Other Receivables?
Other Receivables
6.1B
KRW
Based on the financial report for Dec 31, 2025, Samjin Pharmaceutical Co Ltd's Other Receivables amounts to 6.1B KRW.
What is Samjin Pharmaceutical Co Ltd's Other Receivables growth rate?
Other Receivables CAGR 10Y
44%
Over the last year, the Other Receivables growth was 3 996%. The average annual Other Receivables growth rates for Samjin Pharmaceutical Co Ltd have been 411% over the past three years , 232% over the past five years , and 44% over the past ten years .
